First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors
暂无分享，去创建一个
E. Calleja | A. Shimomura | U. Banerji | M. Nishio | S. Ohkubo | Shigenobu Suzuki | S. Kondo | T. Doi | N. Yamamoto | K. Shitara | A. Kawazoe | R. Sundar | A. Horiike | S. Kitazono | N. Yanagitani | Y. Fujiwara | Y. Kuboki | I. Ohno | F. Ohyanagi